Brain Vascular and Neurocognitive Health

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 16, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

September 17, 2025

Conditions
Cognitive DeclineCognitive DysfunctionAlzheimer DiseaseVascular Disease, Peripheral
Interventions
DEVICE

Transcranial Photobiomodulation

The transcranial photobiomodulation will be delivered through the Neuradiant 1070 Plus-Programmable 4-Quadrant Photobiomodulation System. This is a commercially available helmet that will be purchased from a commercially available source.

DEVICE

Transcranial Photobiomodulation helmet (Neuradiant 1070 Plus) with no light administered

In this condition the participants will wear the Transcranial Photobiomodulation helmet (Neuradiant 1070 Plus); however, the light will not be administered.

Trial Locations (1)

76010

UT Arlington - Science and Engineering Innovation and Research Building, Arlington

All Listed Sponsors
lead

The University of Texas at Arlington

OTHER

NCT06497413 - Brain Vascular and Neurocognitive Health | Biotech Hunter | Biotech Hunter